AAPL317.31+1.99 (+0.63%) ▲|ABBV248.00-0.08 (-0.03%) ▼|ABT92.11-1.82 (-1.94%) ▼|ACN138.52+3.29 (+2.43%) ▲|ADBE230.61+6.97 (+3.12%) ▲|AMAT575.39-27.11 (-4.50%) ▼|AMD534.39-23.50 (-4.21%) ▼|AMGN360.45-2.94 (-0.81%) ▼|AMT169.50+0.91 (+0.54%) ▲|AMZN247.31+1.97 (+0.80%) ▲|AVGO384.05-15.92 (-3.98%) ▼|AXP354.43+3.85 (+1.10%) ▲|BA215.51-6.77 (-3.05%) ▼|BAC59.50-0.17 (-0.28%) ▼|BKNG175.80-2.59 (-1.45%) ▼|BLK1,031.56-4.55 (-0.44%) ▼|BMY59.34+1.76 (+3.06%) ▲|BNY151.27-0.65 (-0.43%) ▼|BRK-B496.85+3.14 (+0.64%) ▲|C140.71-0.08 (-0.06%) ▼|CAT931.47-20.94 (-2.20%) ▼|CL93.21+0.97 (+1.05%) ▲|CMCSA23.97+0.40 (+1.70%) ▲|COF203.02+1.50 (+0.74%) ▲|COP112.85+3.81 (+3.49%) ▲|COST926.43+10.18 (+1.11%) ▲|CRM171.22+7.90 (+4.84%) ▲|CSCO119.25-2.06 (-1.70%) ▼|CVS105.90+1.75 (+1.68%) ▲|CVX182.20+5.80 (+3.29%) ▲|DE585.64-1.22 (-0.21%) ▼|DHR200.16+1.11 (+0.56%) ▲|DIS96.00+0.38 (+0.40%) ▲|DUK126.86+1.38 (+1.10%) ▲|EMR135.38-3.50 (-2.52%) ▼|FDX313.74-0.95 (-0.30%) ▼|GD372.78-2.28 (-0.61%) ▼|GE353.42-5.85 (-1.63%) ▼|GEV1,042.60-48.97 (-4.49%) ▼|GILD131.40+1.57 (+1.21%) ▲|GM76.72-1.13 (-1.45%) ▼|GOOG350.67-4.36 (-1.23%) ▼|GOOGL352.51-4.67 (-1.31%) ▼|GS1,045.91-9.27 (-0.88%) ▼|HD337.11-6.19 (-1.80%) ▼|HON222.25-4.17 (-1.84%) ▼|IBM290.23+2.67 (+0.93%) ▲|INTC103.12-6.72 (-6.12%) ▼|INTU289.76+14.80 (+5.38%) ▲|ISRG407.12+0.34 (+0.08%) ▲|JNJ257.77+0.79 (+0.31%) ▲|JPM334.53-1.94 (-0.58%) ▼|KO84.25+0.76 (+0.91%) ▲|LIN524.06-5.73 (-1.08%) ▼|LLY1,181.87-6.71 (-0.56%) ▼|LMT520.68-2.54 (-0.49%) ▼|LOW207.70-3.93 (-1.86%) ▼|LRCX329.92-20.41 (-5.83%) ▼|MA537.70+10.96 (+2.08%) ▲|MCD272.61-1.99 (-0.72%) ▼|MDLZ59.86+1.03 (+1.75%) ▲|MDT83.57-0.30 (-0.36%) ▼|META656.73-12.48 (-1.86%) ▼|MMM157.70+0.18 (+0.11%) ▲|MO71.87+0.08 (+0.11%) ▲|MRK124.03+0.49 (+0.40%) ▲|MS221.09-1.19 (-0.54%) ▼|MSFT390.99+5.89 (+1.53%) ▲|MU937.00-42.30 (-4.32%) ▼|NEE88.38+0.42 (+0.48%) ▲|NFLX73.83+0.46 (+0.63%) ▲|NKE43.76-0.61 (-1.37%) ▼|NOW111.26+3.55 (+3.30%) ▲|NVDA203.53-7.43 (-3.52%) ▼|ORCL131.54-9.10 (-6.47%) ▼|PEP138.49+1.11 (+0.81%) ▲|PFE24.48+0.31 (+1.28%) ▲|PG148.37+1.33 (+0.90%) ▲|PLTR130.04+3.25 (+2.56%) ▲|PM180.19-1.43 (-0.79%) ▼|QCOM183.98-5.18 (-2.74%) ▼|RTX196.39+0.46 (+0.23%) ▲|SBUX107.34+1.33 (+1.25%) ▲|SCHW102.38-0.74 (-0.72%) ▼|SO96.47+0.86 (+0.90%) ▲|SPG219.49+0.72 (+0.33%) ▲|T21.55+0.42 (+1.99%) ▲|TMO528.51+1.46 (+0.28%) ▲|TMUS188.41+0.80 (+0.43%) ▲|TSLA394.76-13.00 (-3.19%) ▼|TXN298.57-12.89 (-4.14%) ▼|UBER74.26-0.28 (-0.38%) ▼|UNH429.09+4.47 (+1.05%) ▲|UNP289.13+2.17 (+0.76%) ▲|UPS112.89+0.42 (+0.37%) ▲|USB62.34-0.07 (-0.11%) ▼|V357.75+8.78 (+2.52%) ▲|VZ42.68+0.56 (+1.33%) ▲|WFC87.67+0.51 (+0.59%) ▲|WMT114.78+0.88 (+0.77%) ▲|XOM144.51+5.63 (+4.05%) ▲|AAPL317.31+1.99 (+0.63%) ▲|ABBV248.00-0.08 (-0.03%) ▼|ABT92.11-1.82 (-1.94%) ▼|ACN138.52+3.29 (+2.43%) ▲|ADBE230.61+6.97 (+3.12%) ▲|AMAT575.39-27.11 (-4.50%) ▼|AMD534.39-23.50 (-4.21%) ▼|AMGN360.45-2.94 (-0.81%) ▼|AMT169.50+0.91 (+0.54%) ▲|AMZN247.31+1.97 (+0.80%) ▲|AVGO384.05-15.92 (-3.98%) ▼|AXP354.43+3.85 (+1.10%) ▲|BA215.51-6.77 (-3.05%) ▼|BAC59.50-0.17 (-0.28%) ▼|BKNG175.80-2.59 (-1.45%) ▼|BLK1,031.56-4.55 (-0.44%) ▼|BMY59.34+1.76 (+3.06%) ▲|BNY151.27-0.65 (-0.43%) ▼|BRK-B496.85+3.14 (+0.64%) ▲|C140.71-0.08 (-0.06%) ▼|CAT931.47-20.94 (-2.20%) ▼|CL93.21+0.97 (+1.05%) ▲|CMCSA23.97+0.40 (+1.70%) ▲|COF203.02+1.50 (+0.74%) ▲|COP112.85+3.81 (+3.49%) ▲|COST926.43+10.18 (+1.11%) ▲|CRM171.22+7.90 (+4.84%) ▲|CSCO119.25-2.06 (-1.70%) ▼|CVS105.90+1.75 (+1.68%) ▲|CVX182.20+5.80 (+3.29%) ▲|DE585.64-1.22 (-0.21%) ▼|DHR200.16+1.11 (+0.56%) ▲|DIS96.00+0.38 (+0.40%) ▲|DUK126.86+1.38 (+1.10%) ▲|EMR135.38-3.50 (-2.52%) ▼|FDX313.74-0.95 (-0.30%) ▼|GD372.78-2.28 (-0.61%) ▼|GE353.42-5.85 (-1.63%) ▼|GEV1,042.60-48.97 (-4.49%) ▼|GILD131.40+1.57 (+1.21%) ▲|GM76.72-1.13 (-1.45%) ▼|GOOG350.67-4.36 (-1.23%) ▼|GOOGL352.51-4.67 (-1.31%) ▼|GS1,045.91-9.27 (-0.88%) ▼|HD337.11-6.19 (-1.80%) ▼|HON222.25-4.17 (-1.84%) ▼|IBM290.23+2.67 (+0.93%) ▲|INTC103.12-6.72 (-6.12%) ▼|INTU289.76+14.80 (+5.38%) ▲|ISRG407.12+0.34 (+0.08%) ▲|JNJ257.77+0.79 (+0.31%) ▲|JPM334.53-1.94 (-0.58%) ▼|KO84.25+0.76 (+0.91%) ▲|LIN524.06-5.73 (-1.08%) ▼|LLY1,181.87-6.71 (-0.56%) ▼|LMT520.68-2.54 (-0.49%) ▼|LOW207.70-3.93 (-1.86%) ▼|LRCX329.92-20.41 (-5.83%) ▼|MA537.70+10.96 (+2.08%) ▲|MCD272.61-1.99 (-0.72%) ▼|MDLZ59.86+1.03 (+1.75%) ▲|MDT83.57-0.30 (-0.36%) ▼|META656.73-12.48 (-1.86%) ▼|MMM157.70+0.18 (+0.11%) ▲|MO71.87+0.08 (+0.11%) ▲|MRK124.03+0.49 (+0.40%) ▲|MS221.09-1.19 (-0.54%) ▼|MSFT390.99+5.89 (+1.53%) ▲|MU937.00-42.30 (-4.32%) ▼|NEE88.38+0.42 (+0.48%) ▲|NFLX73.83+0.46 (+0.63%) ▲|NKE43.76-0.61 (-1.37%) ▼|NOW111.26+3.55 (+3.30%) ▲|NVDA203.53-7.43 (-3.52%) ▼|ORCL131.54-9.10 (-6.47%) ▼|PEP138.49+1.11 (+0.81%) ▲|PFE24.48+0.31 (+1.28%) ▲|PG148.37+1.33 (+0.90%) ▲|PLTR130.04+3.25 (+2.56%) ▲|PM180.19-1.43 (-0.79%) ▼|QCOM183.98-5.18 (-2.74%) ▼|RTX196.39+0.46 (+0.23%) ▲|SBUX107.34+1.33 (+1.25%) ▲|SCHW102.38-0.74 (-0.72%) ▼|SO96.47+0.86 (+0.90%) ▲|SPG219.49+0.72 (+0.33%) ▲|T21.55+0.42 (+1.99%) ▲|TMO528.51+1.46 (+0.28%) ▲|TMUS188.41+0.80 (+0.43%) ▲|TSLA394.76-13.00 (-3.19%) ▼|TXN298.57-12.89 (-4.14%) ▼|UBER74.26-0.28 (-0.38%) ▼|UNH429.09+4.47 (+1.05%) ▲|UNP289.13+2.17 (+0.76%) ▲|UPS112.89+0.42 (+0.37%) ▲|USB62.34-0.07 (-0.11%) ▼|V357.75+8.78 (+2.52%) ▲|VZ42.68+0.56 (+1.33%) ▲|WFC87.67+0.51 (+0.59%) ▲|WMT114.78+0.88 (+0.77%) ▲|XOM144.51+5.63 (+4.05%) ▲|
26.9 C
New York
Tuesday, July 14, 2026

Tag: value

ROCKIT READY TO LAUNCH STRONG 2025 SEASON

DUBAI, UAE, June 22, 2025 /PRNewswire/ -- Innovative New Zealand snack sized apple company, Rockit Global is gearing up for its 2025 season with a...

ROCKIT READY TO LAUNCH STRONG 2025 SEASON

DUBAI, UAE, June 22, 2025 /PRNewswire/ -- Innovative New Zealand snack sized apple company, Rockit Global is gearing up for its 2025 season with a...

SK Group and AWS Team Up to Build Cloud Computing Infrastructure to Support AI Innovation

SK Group, in partnership with AWS, will provide data center infrastructure for a new AWS AI Zone location in Ulsan that will support AI...

XRP Struggles to Break $3 Barrier, While PFMCrypto Launches Innovative XRP Cloud Mining Contracts to Widespread Interest

While XRP Remains Range-Bound, PFMCrypto’s New XRP Cloud Mining Model Drives Holder Participation and Ecosystem Activity
While XRP Remains Range-Bound, PFMCrypto’s New XRP Cloud Mining Model Drives Holder Participation and Ecosystem Activity

Kaanch Network Presale Positions Project Among Top Altcoins and Best Crypto Opportunities of 2025

DUBAI, United Arab Emirates, June 21, 2025 (GLOBE NEWSWIRE) -- Kaanch Network’s token is set to be listed on BitMart and LBank exchanges on June 30th, an important milestone in the project’s mission to revolutionize decentralized finance and asset management. Built on a scalable and affordable Layer 1 blockchain with real-world applications, Kaanch offers developers, business owners, and investors a compelling platform for growth in 2025 and beyond.

No Deposit Casino 2025: Uptown Aces Launches No Deposit Bonus

Uptown Aces has unveiled a new no deposit bonus to incentivize new casino players looking to explore the online gaming world.
Uptown Aces has unveiled a new no deposit bonus to incentivize new casino players looking to explore the online gaming world.

INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit...

SAN DIEGO, June 21, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Tempus AI, Inc. (NASDAQ: TEM) common stock between August 6, 2024 and May 27, 2025, both dates inclusive (the “Class Period”), have until August 12, 2025 to seek appointment as lead plaintiff of the Tempus AI class action lawsuit. Captioned Shouse v. Tempus AI, Inc., No. 25-cv-06534 (N.D. Ill.), the Tempus AI class action lawsuit charges Tempus AI and certain of Tempus AI’s top executives with violations of the Securities Exchange Act of 1934.

Gan & Lee Pharmaceuticals Presented Multiple Results in Novel Diabetes Therapies at the American Diabetes Association’s 85th Scientific Sessions

In a Phase 2a clinical trial, the GLP-1 RA bofanglutide injection demonstrated a favorable safety and tolerability profile after 23 weeks of once weekly...

Gan & Lee Pharmaceuticals Presented Multiple Results in Novel Diabetes Therapies at the American Diabetes Association’s 85th Scientific Sessions

In a Phase 2a clinical trial, the GLP-1 RA bofanglutide injection demonstrated a favorable safety and tolerability profile after 23 weeks of once weekly...

BexBack Launches $50 Welcome Bonus and 100% Deposit Match to Empower Crypto Traders with 100x Leverage

SINGAPORE, June 21, 2025 (GLOBE NEWSWIRE) -- BexBack Exchange has launched an aggressive new promotion to empower both new and seasoned crypto traders: a $50 welcome bonus and a 100% deposit match for all new users. As the crypto market braces for another period of high volatility, BexBack is making futures trading more accessible and profitable than ever. With up to 100x leverage, zero KYC requirements, and support for over 50 digital assets, the platform provides an ideal environment for those seeking to capitalize on market swings without large upfront capital.

Lilly’s oral GLP-1, orforglipron, showed compelling efficacy and a safety profile consistent with injectable GLP-1 medicines, in complete Phase 3 results published in The...

The investigational once-daily pill lowered A1C by an average of 1.3% to 1.6% across doses, with improvements seen as early as four weeks, in adults...

New data demonstrates robust efficacy of Vyepti® (eptinezumab) in otherwise difficult-to-treat patients with severe migraine

The full results of the phase IV RESOLUTION trial were presented at the European Academy of Neurology 2025 Annual Congress, where Vyepti® (eptinezumab) demonstrated...

New data demonstrates robust efficacy of Vyepti® (eptinezumab) in otherwise difficult-to-treat patients with severe migraine

The full results of the phase IV RESOLUTION trial were presented at the European Academy of Neurology 2025 Annual Congress, where Vyepti® (eptinezumab) demonstrated...

New data from phase III trial confirms efficacy of Vyepti® (eptinezumab) in Asian population with chronic migraine

The full results of the phase III registrational SUNRISE trial were presented at the European Academy of Neurology 2025 Annual Congress, where eptinezumab demonstrated statistically...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsValue